跳至主要内容
临床试验/NCT01103726
NCT01103726已完成1 期

Evaluation Of Regional Glucose Metabolism In Striatum As Measured By [18f]-Fluorodeoxyglucose Positron Emission Tomography Following Single Oral Dose Administration Of PF-02545920 In Healthy Subjects

Pfizer1 个研究点 分布在 1 个国家目标入组 34 人开始时间: 2010年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
发起方
Pfizer
入组人数
34
试验地点
1
主要终点
Glucose metabolic rates in striatum using standard Region of Interest (ROI) analysis method.

研究概览

简要总结

We hypothesize that PF-02545920 will increase glucose metabolism in a part of the brain called the striatum.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy right-handed male and female subjects between the ages of 18 and 55 years, inclusive
  • Body Mass Index (BMI) of 17.5 to 30.5 kg/m2; and a total body weight >50 kg (110 lbs)
  • An informed consent document signed and dated by the subject
  • Subjects who are willing and able to comply with scheduled visits, treatment plan, laboratory tests, and other study procedures

排除标准

  • Women of reproductive potential
  • History of agranulocytosis or movement disorder
  • Positron Emission Tomography (PET) or Magnetic Resonance Imaging (MRI) contraindications

研究组 & 干预措施

Stage 1

Experimental

干预措施: PF-02545920 (Drug)

Stage 1

Experimental

干预措施: Placebo (Drug)

Stage 2

Experimental

干预措施: PF-02545920 (Drug)

Stage 2

Experimental

干预措施: Placebo (Drug)

结局指标

主要结局

Glucose metabolic rates in striatum using standard Region of Interest (ROI) analysis method.

时间窗: Stage 1: Day 1, 8. Stage 2: Day 1, 8, 15.

次要结局

  • Whole brain glucose metabolic rate.(Stage 1: Day 1, 8. Stage 2: Day 1, 8, 15.)
  • Relative glucose metabolic rate in striatum.(Stage 1: Day 1, 8. Stage 2: Day 1, 8, 15.)
  • Glucose metabolic rate in striatal subregions: putamen and caudate nucleus.(Stage 1: Day 1, 8. Stage 2: Day 1, 8, 15.)
  • Relative glucose metabolic rate in striatal subregions: putamen and caudate nucleus.(Stage 1: Day 1, 8. Stage 2: Day 1, 8, 15.)
  • Glucose metabolic rate in striatum determined using data-driven ROI analysis method.(Stage 1: Day 1, 8. Stage 2: Day 1, 8, 15.)
  • Relative glucose metabolic rate in striatum determined using data-driven ROI analysis method.(Stage 1: Day 1, 8. Stage 2: Day 1, 8, 15.)
  • Effect size comparison between standard ROI and data-driven ROI analysis methods using both regional glucose metabolic rate and relative regional glucose metabolic rate.(Stage 1: Day 1, 8. Stage 2: Day 1, 8, 15.)

研究者

发起方
Pfizer
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Evaluation Of Striatal Glucose Metabolism With... | 临床试验